Industry Insights · Brain–Computer Interface
China prices BCI: invasive implantation fee RMB 6,000–6,600 per case
Innovative medical products often stall at 'approved but un-billable'. BCI is the first to clear that step.
Pricing details
- Invasive BCI implantation fee RMB 6,000–6,600 per case (provincial guide ranges);
- Non-invasive BCI fitting fee ~RMB 960;
- ~10% patient co-pay, mostly reimbursable.
Why it's a milestone
Innovative products commonly face 'no billing item' — a registration certificate but no compliant way to charge in hospitals. Setting pricing items institutionally clears the payment path for BCI clinical use.
Speed of execution
From March approval to April coding and price-setting to provincial guide prices, the sequence shows efficient coordination of approval, insurance pricing and clinical use.
The BIO angle
FAQ
How much is invasive BCI surgery?
Provinces set the invasive implantation fee around RMB 6,000–6,600 per case and non-invasive fitting around RMB 960; ~10% co-pay, mostly reimbursable.
Is a 'pricing item' the same as 'reimbursement'?
Not exactly. A pricing item first creates a billable service with a guide price — a prerequisite for compliant charging; actual reimbursement ratios depend on local policy.
What does it mean for the industry?
Unlocking payment markedly speeds clinical adoption and volume — a key step in commercializing innovative devices.
Related reading
- BCI in 2026: Technology Paths, Global Landscape and China's Rise | BIO Insights
- Brain–Spine Interfaces Heat Up: a 'Neural Bridge' Route and a $40M+ Angel Round | BIO Insights
- Map of China's Core BCI Companies: Three Tiers and Technology Routes | BIO Insights
Note: an original analysis compiled from public industry information; figures and conclusions per official/original sources. Not investment advice.
Building in China's medical-device market?
From advanced medical silicone/polymers to material selection, regulatory and supply, BIO helps global and local partners move from selection to landed supply in China.